# Phase 0 Closure Readiness Checklist V0.1 - OpenEMR IM Core

## AI-Assisted Solo-Owner Applicability

Required reviewer roles in this checklist are future Phase 0 closure roles, not
mandatory internal merge gates for an eligible documentation-stage change.
Eligible work uses the AI-Assisted Solo-Owner Governance Policy V0.1.

The Project Owner decision under that policy does not close Phase 0, authorize a
phase transition, or claim independent review, clinical validation, compliance,
certification, production readiness, or clinical-use authorization.

## 1. Purpose

This document defines a readiness checklist for evaluating whether OpenEMR IM Core Phase 0 may later be considered for closure.

This checklist is not a Phase 0 closure report.

This checklist does not state that Phase 0 is complete.

This checklist does not authorize runtime implementation, clinical use, production use, demo use, pilot use, commercial use, regulatory compliance claims, cybersecurity certification claims, medical-device readiness claims, or clinical-use authorization.

The purpose is to create a controlled, reviewable basis for identifying remaining Phase 0 gaps before any future closure report is prepared.

---

## 2. Scope

This checklist covers Phase 0 readiness topics for:

- Documentation governance.
- Safety boundary governance.
- Claims control.
- Requirements foundation.
- Traceability foundation.
- Risk foundation.
- Evidence foundation.
- Standards awareness.
- Documentation indexing.
- Future phase-gate readiness.
- Reviewer role coverage.
- Remaining gap identification.

This checklist is documentation-only and planning-stage only.

---

## 3. Out of Scope

This checklist does not include:

- Runtime implementation.
- SQL execution.
- Database migration.
- FHIR/API implementation.
- Frontend implementation.
- OpenEMR core-sensitive changes.
- Runtime AI.
- Prompt execution.
- AI/model integration.
- Clinical decision support implementation.
- Diagnosis logic.
- Treatment recommendation logic.
- Prescribing logic.
- Emergency triage logic.
- Patient-facing AI.
- PHI or real patient data.
- Credentials or secrets.
- Sensitive logs.
- Database dumps.
- Clinical validation.
- Production deployment.
- Regulatory submission.
- Cybersecurity certification.
- Medical-device classification decision.
- Phase 0 closure approval.

---

## 4. Phase 0 Definition

For OpenEMR IM Core, Phase 0 means:

- Governance foundation establishment.
- Safety boundary establishment.
- Non-authorization boundary establishment.
- Documentation-first planning.
- Initial requirements planning.
- Initial traceability planning.
- Initial risk planning.
- Initial evidence planning.
- Standards awareness planning.
- Claims-control planning.
- Future phase-gate preparation.

Phase 0 does not mean:

- Clinical readiness.
- Production readiness.
- Regulatory compliance.
- Cybersecurity certification.
- Medical-device readiness.
- Runtime readiness.
- AI/ML implementation readiness.

---

## 5. Closure Readiness Status Legend

| Status | Meaning |
|---|---|
| Ready for closure review | Sufficient documentation exists for reviewer assessment, but closure is not automatically approved |
| Partially ready | Some documentation exists, but gaps remain |
| Not ready | Required documentation or review basis is missing |
| Future-gated | Item belongs to a later phase and must not be interpreted as current authorization |
| Not applicable at current stage | Item is not applicable to Phase 0 but may require future review |
| Evidence needed | Planning exists, but supporting evidence is not yet populated |

---

## 6. Phase 0 Closure Readiness Checklist

| Area | Readiness question | Current status | Evidence or source artifact | Gap / action needed | Closure impact |
|---|---|---|---|---|---|
| Documentation governance | Are core documentation structures established? | Partially ready | Documentation Index and Review Cadence V0.1 / Documentation Inventory and Artifact Status Matrix V0.1 | Review record and change-control SOP still needed | Medium |
| Safety boundaries | Are safety and non-authorization boundaries explicit? | Ready for closure review | Root Safety and Non-Authorization Notice V0.1 / Regulatory and CDS Boundary Statement V0.1 | Maintain boundary consistency across future PRs | High |
| Claims control | Are prohibited claims clearly controlled? | Ready for closure review | Root Safety and Non-Authorization Notice V0.1 / Standards Applicability and Awareness Matrix V0.1 | Continue claim-control review in each PR | High |
| Requirements foundation | Is a requirements management basis present? | Partially ready | Requirements Management Plan V0.1 / Requirements Register Starter V0.1 | Requirements population still incomplete | High |
| Traceability foundation | Is traceability structure present? | Partially ready | Traceability Matrix V0.1 / Requirements Traceability Population Starter V0.1 | More populated traceability rows needed | High |
| Risk foundation | Is risk structure present? | Partially ready | Risk Register V0.1 / Workflow Risk Mapping V0.1 | Initial risk entries and scoring still needed | High |
| Evidence foundation | Is evidence structure present? | Partially ready | Evidence Registry and Templates V0.1 | Evidence ID population still needed | High |
| Standards awareness | Is standards awareness documented without compliance claims? | Ready for closure review | Standards Applicability and Awareness Matrix V0.1 | Future applicability review still required | Medium |
| Human factors | Is usability or human factors planning represented? | Partially ready | Human Factors and Usability Risk Plan V0.1 if available | Future usability-risk linkage needed | Medium |
| Security and privacy | Are security and no-PHI boundaries represented? | Partially ready | Threat Model and Data Governance V0.1 if available / Root Safety Notice V0.1 | Future cybersecurity framework and evidence still needed | High |
| Documentation indexing | Are major artifacts discoverable? | Partially ready | Documentation Index and Review Cadence V0.1 | Automated or semi-automated unindexed-document check not yet present | Medium |
| Reviewer roles | Are expected reviewer roles identified? | Partially ready | Multiple governance artifacts | Formal reviewer approval matrix still needed | Medium |
| Phase-gate control | Is future phase-gating represented? | Partially ready | Lifecycle Phase Gate Control V0.1 / Comprehensive Governance Roadmap V0.1 | Formal Phase 0 closure report still needed | High |
| Runtime boundary | Is runtime work still prohibited? | Ready for closure review | Root Safety Notice V0.1 | Must remain prohibited until separately approved | Critical |
| AI/ML boundary | Is AI/model integration still future-gated? | Ready for closure review | Root Safety Notice V0.1 / Regulatory and CDS Boundary Statement V0.1 | Must remain future-gated only | Critical |
| Clinical-use boundary | Is clinical use clearly prohibited? | Ready for closure review | Root Safety Notice V0.1 | Must remain prohibited | Critical |

---

## 7. Current Phase 0 Strengths

Current strengths include:

- Documentation-first approach is established.
- Safety and non-authorization language is explicit.
- Claims-control language is strong.
- Documentation index exists and is being maintained.
- Documentation inventory exists.
- Requirements, traceability, risk, evidence, and standards-awareness foundations exist.
- Root safety notice now protects repository-level interpretation.
- AI-assisted development boundaries are explicit.
- Runtime, SQL, FHIR/API, frontend, AI/model integration, PHI, clinical-use, and production-use boundaries remain prohibited.

---

## 8. Current Phase 0 Gaps

Current gaps include:

- Phase 0 closure report does not yet exist.
- Evidence ID registry population remains incomplete.
- Risk register initial population remains incomplete.
- Requirements traceability population remains limited.
- Formal reviewer approval matrix remains incomplete.
- Document review record template remains incomplete.
- Documentation-only PR SOP remains incomplete.
- Document change-control SOP remains incomplete.
- Supersession and retirement process remains incomplete.
- Automated unindexed-document check remains incomplete.
- Formal clinical safety review record remains incomplete.
- Future regulatory pathway memo remains future-gated.
- Future cybersecurity evidence remains unpopulated.
- No clinical validation evidence exists.
- No production readiness evidence exists.
- No regulatory compliance evidence exists.
- No cybersecurity certification evidence exists.

---

## 9. No-Go Conditions for Phase 0 Closure

Phase 0 should not be considered ready for closure if any of the following occur:

- Runtime implementation is introduced.
- SQL execution is introduced.
- Database migration is introduced.
- FHIR/API implementation is introduced.
- Frontend implementation is introduced.
- Runtime AI is introduced.
- Prompt execution is introduced.
- AI/model integration is introduced.
- PHI or real patient data is introduced.
- Clinical-use authorization is claimed.
- Production readiness is claimed.
- Clinical validation is claimed.
- Regulatory compliance is claimed.
- Cybersecurity certification is claimed.
- Medical-device readiness is claimed.
- Required documentation index updates are missing.
- Major Phase 0 artifacts are not discoverable.
- Known Phase 0 gaps are not identified.
- Closure report is created without gap review.

---

## 10. Conditional-Go Conditions for Future Closure Report

A future Phase 0 closure report may be considered only if:

- Major Phase 0 artifacts are indexed.
- Safety and non-authorization boundaries are intact.
- Claims-control language remains consistent.
- Requirements foundation is documented.
- Traceability foundation is documented.
- Risk foundation is documented.
- Evidence foundation is documented.
- Standards awareness is documented without compliance claims.
- Current gaps are explicitly documented.
- Open risks are explicitly documented.
- Reviewer roles are identified.
- No runtime implementation is introduced.
- No PHI or real patient data is introduced.
- No clinical-use, production-use, regulatory-compliance, cybersecurity-certification, or medical-device readiness claim is introduced.

---

## 11. Required Reviewer Roles for Future Closure Review

Future Phase 0 closure review should include, as applicable:

- Governance Owner.
- Documentation Owner.
- Technical Owner.
- Clinical Safety Owner.
- Risk Owner.
- Evidence Reviewer.
- Privacy-Security Owner.
- Regulatory Reviewer.
- AI Governance Owner.
- Operations Owner.

This checklist does not confirm that these roles have approved Phase 0 closure.

---

## 12. Relationship to Existing Artifacts

| Source ID | Artifact | File path | Relationship |
|---|---|---|---|
| SRC-ROADMAP-001 | Comprehensive Governance and Future Clinical-Use Readiness Roadmap V0.1 | custom/im-core/docs/roadmap/comprehensive-governance-and-future-clinical-use-readiness-roadmap-v0.1.md | Defines the broader governance roadmap and near-term Phase 0 needs |
| SRC-INDEX-001 | Documentation Index and Review Cadence V0.1 | custom/im-core/docs/index/documentation-index-and-review-cadence-v0.1.md | Provides documentation discoverability |
| SRC-INVENTORY-001 | Documentation Inventory and Artifact Status Matrix V0.1 | custom/im-core/docs/index/documentation-inventory-and-artifact-status-matrix-v0.1.md | Provides artifact status and gap visibility |
| SRC-SAFETY-001 | Root Safety and Non-Authorization Notice V0.1 | custom/im-core/docs/governance/root-safety-and-non-authorization-notice-v0.1.md | Defines repository-level safety and non-authorization boundaries |
| SRC-STD-001 | Standards Applicability and Awareness Matrix V0.1 | custom/im-core/docs/regulatory/standards-applicability-and-awareness-matrix-v0.1.md | Defines standards awareness without compliance claims |
| SRC-REQ-001 | Requirements Management Plan V0.1 | custom/im-core/docs/requirements/requirements-management-plan-v0.1.md | Defines requirements management basis |
| SRC-TRACE-001 | Requirements Traceability Population Starter V0.1 | custom/im-core/docs/requirements/requirements-traceability-population-starter-v0.1.md | Defines traceability population starter |
| SRC-RISK-001 | Risk Register V0.1 | custom/im-core/docs/risk/risk-register-v0.1.md | Defines risk register basis |
| SRC-EVID-001 | Evidence Registry and Templates V0.1 | custom/im-core/docs/evidence/evidence-registry-and-templates-v0.1.md | Defines evidence structure |

---

## 13. Risks

| Risk | Impact | Control |
|---|---|---|
| Checklist is mistaken for closure approval | Premature Phase 0 closure claims | Explicit statement that this is not a closure report |
| Closure readiness is mistaken for clinical readiness | Unsupported clinical-use assumptions | Explicit non-authorization and no-clinical-use language |
| Governance maturity is overstated | Weak future review discipline | Status legend and gap list |
| Evidence planning is mistaken for evidence completion | Unsupported validation claims | Evidence-needed status and no-validation language |
| Phase 0 closure report is created prematurely | Incomplete governance baseline | No-go and conditional-go conditions |
| Future runtime work is inferred | Premature implementation | Explicit runtime prohibition |

---

## 14. Review Expectations

This checklist should be reviewed before:

- Any Phase 0 closure report is drafted.
- Any future phase gate is proposed.
- Any runtime implementation is proposed.
- Any SQL, database, FHIR/API, frontend, AI, or PHI-related change is proposed.
- Any clinical-use, production-use, regulatory-compliance, cybersecurity-certification, or medical-device readiness claim is proposed.

---

## 15. Definition of Done

This document is complete when:

- Purpose is documented.
- Scope is documented.
- Out of scope is documented.
- Phase 0 definition is documented.
- Closure readiness status legend is documented.
- Phase 0 closure readiness checklist is documented.
- Current strengths are documented.
- Current gaps are documented.
- No-go conditions are documented.
- Conditional-go conditions are documented.
- Required reviewer roles are documented.
- Relationship to existing artifacts is documented.
- Risks are documented.
- Review expectations are documented.
- No runtime implementation is introduced.
- No SQL execution is introduced.
- No database migration is introduced.
- No FHIR/API implementation is introduced.
- No frontend implementation is introduced.
- No OpenEMR core-sensitive change is introduced.
- No runtime AI is introduced.
- No prompt execution is introduced.
- No AI/model integration is introduced.
- No PHI, real patient data, credentials, secrets, sensitive logs, or database dumps are introduced.
- No unsupported demo, pilot, production, commercial, clinical validation, regulatory compliance, cybersecurity certification, medical-device readiness, or clinical-use authorization claim is introduced.
- No Phase 0 closure claim is introduced.

---

## 16. After-Merge Action

After this PR is merged, the next documentation step should be separately approved based on the current roadmap and remaining Phase 0 gaps.

The Phase 0 governance closure gap summary and formal reviewer approval matrix now exist as documentation-stage artifacts; any next documentation step should be separately approved based on remaining Phase 0 gaps, evidence population needs, and formal reviewer record completion.

Do not treat this checklist as Phase 0 closure.

---

## 17. Status

Documentation-only Phase 0 closure readiness checklist.

Planning-stage only.

Future-gated only.

Not a Phase 0 closure report.

No Phase 0 closure claim.

Not for clinical use.

Not production-ready.

Not clinically validated.

No regulatory compliance claim.

No cybersecurity certification claim.

No medical-device readiness claim.

No runtime implementation.

No SQL execution.

No database migration.

No FHIR/API implementation.

No frontend implementation.

No runtime AI.

No prompt execution.

No AI/model integration.
